Pamela A. Swiggard

No open positions remaining

Consumer Services

Health Technology

Commercial Services

Profile

Pamela A. Swiggard worked as a Director of Regulatory Affairs at Endo Pharmaceuticals, Inc. and as a Vice President and Head of Regulatory Affairs at Trevena, Inc. She also worked as a VP of Regulatory Affairs and Quality Assurance at Fibrocell Science, Inc. Ms. Swiggard holds a graduate degree from Temple University and an undergraduate degree from The Pennsylvania State University.

Former positions of Pamela A. Swiggard

Companies	Position	End
FIBROCELL SCIENCE, INC.	General Counsel	31/08/2018
Endo Pharmaceuticals, Inc. Endo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products	General Counsel	-
TREVENA, INC.	General Counsel	-

See the detail of Pamela A. Swiggard's experience

Training of Pamela A. Swiggard

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Pamela A. Swiggard's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	5
Fibrocell Science, Inc. Fibrocell Science, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as an autologous cell and gene therapy company focused on development of personalized biologics to treat rare skin and connective tissue diseases	Commercial Services
Endo Pharmaceuticals, Inc. Endo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products	Health Technology
Temple University (Pennsylvania) Temple University (Pennsylvania) Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
The Pennsylvania State University The Pennsylvania State University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Trevena, Inc. Trevena, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company focused on the development and commercialization of novel medicines for patients affected by central nervous system	Health Technology